PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chances of lifting all virus restrictions in UK in June "looking good"

Sun, 23rd May 2021 20:04

(Alliance News) - The possibility of all coronavirus restrictions being lifted next month is "looking good", the chief executive of the UK Health Security Agency has said.

Under the UK government's road map, the final stage of the unlocking is due to take place on June 21 at the earliest.

However, Jenny Harries urged the public to be cautious to avoid another lockdown, warning that the new Indian variant has become the "dominant strain" in some parts of the country.

She told BBC One's The Andrew Marr Show: "It's looking good if people are continuing to observe all of the safety signals, so we should not stop doing what we're doing, particularly in areas where we have that variant of concern, the B1617.2, in the north-west and around London.

"It's really important that people continue to do hands, face, space and work from home, have their jabs and go for tests as well.

"The cases of the B1617.2 variant are rising, they have risen very steeply and much of the media have reported a 160% rise in cases over the week period but they seem to be slightly levelling at the moment.

"It's still very early days."

Harries added: "We all need to be very cautious and I think we all don't want to go back to the sort of lockdowns that we've had, it doesn't matter whether you're on Sage or out in the public, none of us want to return to that sort of restriction."

From June 21 at the earliest, nightclubs are due to reopen and restrictions on large events such as festivals are to be lifted, as are restrictions on the number of people at weddings.

Harries warned that caution should be taken as the new Indian strain is creating a "mixed picture" across the UK.

She added: "If you look at areas such as Bolton and Bedford, for example, in the north-west particularly, it's starting to become the dominant strain and has taken over from the Kent variant, which has been our predominant one over the winter months.

"But that's not the case right across the country, actually if you're in the south-west that's still not the case."

However, Adam Finn, a member of the government's Joint Committee on Vaccination and Immunisation, believed there may be an "adjustment" to the lifting of restrictions on June 21.

Asked how likely it is that measures will be lifted on that date, he told Times Radio on Sunday: "We're effectively in a race with the vaccine programme against the virus.

"We know that we're letting the virus out by spreading it about now, we know that we're progressing well with the vaccine programme, but I think there's going to need to be an adjustment of some sort."

Meanwhile, Home Secretary Priti Patel said there would not be a "green light all the way" to unlocking restrictions.

Patel said: "We all have to be conscientious. All of us that are out and about now, we are distancing, wearing masks, following all the rules.

"That is part of our normal life now and that will continue, and that, of course, will help us to that unlocking on June 21."

The comments come after a study by Public Health England found that the Pfizer Inc coronavirus vaccine is 88% effective against the Indian variant after two doses.

UK Health Secretary Matt Hancock described the outcome as "groundbreaking", while PHE said it expects to see even higher levels of effectiveness against hospital admission and death.

The study, which took place between April 5 and May 16, found that the jab was found to be almost as effective against symptomatic disease from the B1617.2 strain as it is against the Kent variant, with 93% effectiveness.

Meanwhile, the AstraZeneca PLC jab was 60% effective, compared with 66% against the Kent variant over the same period.

Both vaccines were 33% effective against symptomatic disease from the Indian variant three weeks after the first dose, compared with about 50% against the Kent strain.

New data from PHE shows there have been at least 2,889 cases of the Indian variant recorded in England from February 1 this year to May 18.

Of those, 104 cases resulted in a visit to a hospital emergency department, 31 required an overnight hospital admission and six resulted in a death.

The most common strain in England, according to the data, is the Kent variant, with 132,082 cases recorded over the same period.

Some 1,569 people have died with the variant, while 2,011 cases resulted in an overnight hospital admission and 5,238 required a visit to a hospital emergency department.

Separate analysis by PHE indicates that the vaccination programme has so far prevented 13,000 deaths and about 39,100 hospital admissions in older people in England, up to May 9.

Meanwhile, Downing Street said it was looking at ways to publish data on cases transmitted in different settings in a "robust and clear way".

It comes after The Observer reported that data on the spread of the Indian variant in schools had been due to be published this week, but was not included in a PHE report on Thursday.

A Downing Street spokesman said: "Twice a week, Public Health England publish a breakdown of the number of cases of each variant in the UK.

"Given public interest in variants of concern, we are looking at ways to publish cases transmitted in different settings in a robust and clear way. PHE will publish this data in due course."

Latest figures show that more than 60 million doses of coronavirus vaccine have now been given in the UK, including 50 million in England.

By PA Reporters

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.